Polymyositis associated with infliximab treatment for rheumatoid arthritis

Modern Rheumatology

Volumn 16, Issue 6, 2006, Pages 410-411

  Urata, Yukitomo ^a   Wakai, Yuji ^b   Kowatari, Kenji ^b   Nitobe, Taisuke ^b   Mizushima, Yutaka ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Seihoku Central Hospital   (Japan)

Author keywords

Anti tumor necrosis factor antibody; Infliximab; Polymyositis; Rheumatoidarthritis

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; INFLIXIMAB; JO 1 ANTIBODY; METHOTREXATE; PREDNISOLONE; TACROLIMUS;

ADULT; ANTIBODY DETECTION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; MULTIPLE CYCLE TREATMENT; MUSCLE BIOPSY; PHYSICAL EXAMINATION; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; POLYMYOSITIS; PREDNISOLONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845529283     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-006-0523-1     Document Type: Letter

References (9)

1. T Abe T Takeuchi N Miyasaka H Hashimoto H Kondo Y Ichikawa 2006 A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis J Rheumatol 33 37-44 16395748 1:CAS:528:DC%2BD28Xps1ajug%3D%3D
2. M Debandt O Vittecoq V Descamps X Le Loet O Meyer 2003 Anti-TNF-alpha-induced systemic lupus syndrome Clin Rheumatol 22 56-61 12605321 10.1007/s10067-002-0654-5 1:STN:280:DC%2BD3s%2Fpt1egtQ%3D%3D
3. J Musial A Undas M Celinska-Lowenhoff 2003 Polymyositis associated with infliximab treatment for rheumatoid arthritis Rheumatology 42 1566-8 14645861 10.1093/rheumatology/keg388 1:STN:280:DC%2BD3srntFyhug%3D%3D
4. K Shichijo T Mitsui M Kunishige Y Kuroda K Masuda T Matsumoto 2005 Involvement of mitochondria in myasthenia gravis complicated with dermatomyositis and rheumatoid arthritis: A case report Acta Neuropathol 109 539-42 15843907 10.1007/s00401-005-0990-z
5. EA Jenkins RG Hull AL Thomas 1993 D-penicillamine and polymyositis: The significance of the anti-Jo-1 antibody Br J Rheumatol 32 1109-10 8252325 1:STN:280:ByuD2szmt1M%3D
6. GJ Hengstman FH van den Hoogen P Barrera MG Netea A Pieterse LB van de Putte 2003 Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: Preliminary observations Eur Neurol 50 10-5 12824706 10.1159/000070852 1:CAS:528:DC%2BD3sXkvVegsr0%3D
7. E Roddy PA Courtney A Morris 2002 Non-Hodgkin's lymphoma in a patient with refractory dermatomyositis which had been treated with infliximab Rheumatology 41 1194-5 12364644 10.1093/rheumatology/41.10.1194 1:STN:280:DC%2BD38nhtVSntw%3D%3D
8. E Comby P Tanaff D Mariotte V Costentin-Pignol C Marcelli JJ Ballet 2006 Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy J Rheumatol 33 24-30 16395746 1:CAS:528:DC%2BD28Xps1ajtA%3D%3D
9. WA Schmidt W Wetzel R Friedlander R Lange HF Sorensen HJ Lichey 2000 Clinical and serological aspects of patients with anti-Jo-1 antibodies - an evolving spectrum of disease manifestations Clin Rheumatol 19 371-7 11055826 10.1007/s100670070030 1:STN:280:DC%2BD3crgsFWntw%3D%3D